Literature DB >> 17244075

Late reactions in patch tests: a 4-year review from a clinic of occupational dermatology.

Kristiina Aalto-Korte1, Kristiina Alanko, Outi Kuuliala, Riitta Jolanki.   

Abstract

Late patch test reactions on day (D) 10-14, which on subsequent retesting appear in the normal time schedule on D2-D4, indicate active sensitization due to the patch test. The objective of this study was to report our series of late patch test reactions. We analysed the clinical records of all the patients who had reported late reactions for the date of the late reaction, the results of the first patch tests and retesting. Between January 2002 and February 2006, we had a total of 16 patients with late reactions (>or=D10). 12 of them were retested. Retesting confirmed active sensitization to 1 or more allergens in 11 patients (1.3% of 884 patients patch tested). In these 11 cases, none of the late reactions had clear relevance to the symptoms before its appearance. The commonest allergens were paraphenylenediamine (PPD) in 6 patients (0.72% of 826 PPD tests), elecampane (Inula helenium) and black-eyed Susan (Rudbeckia sp. hybr.) extracts in 3 patients, and 4-aminoazobenzene and Disperse Orange 3 in 2 patients. The late reaction did not generally affect the clinical course. Only 1 patient developed new dermatitis possibly due to active sensitization. Late reactions meeting the classic criteria of active sensitization were relatively common in our series from a special clinic of occupational dermatology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17244075     DOI: 10.1111/j.1600-0536.2007.01003.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  1 in total

1.  The necessity of a test reading after 1 week to detect late positive patch test reactions in patients with oral lichen lesions.

Authors:  Camilla Ahlgren; Marléne Isaksson; Halvor Möller; Tony Axéll; Rolf Liedholm; Magnus Bruze
Journal:  Clin Oral Investig       Date:  2013-10-06       Impact factor: 3.573

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.